Company: HRTX
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0000950170-25-028372
Chunk: 1

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
         99.1      Earnings Press Release, dated February 27, 2025                              
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               Heron Therapeutics, Inc.                           
  Date: February 27, 2025      /s/ Ira Duarte                                     
                               Ira Duarte                                         
                               Executive Vice President, Chief Financial Officer